The World Health Organization (WHO) has suspended the supply of India’s biotech Covacin. It also directed the countries receiving the vaccine to take action. However, the World Health Organization has assured that the vaccine is effective and safe. Overall this vaccine is safe.
This suspension has been brought according to the emergency use list. Errors have occurred in the delivery and preparation of vaccines. Known as Good Manufacturing Practice deficiencies. And because of this suspension. Meanwhile, due to this suspension, the export of this vaccine may also be hampered this time. On the other hand, India Biotech has also indicated that the vaccine which was being prepared for export is also being put on hold for the time being.
Bharat Biotech said on Friday that the policy to slow down Covacin production is being pursued for specific reasons. Currently, this covaccine is not supplied to the agency in United Nations procurement. Meanwhile, India Biotech said in a statement that some state-of-the-art equipment was not available due to the Covid supermarket. However, it is firmly stated that the quality of Covacin has never been compromised.